https://www.selleckchem.com/pr....oducts/Carboplatin.h
6 to 2.7%, p 0.001). Long-course NET was significantly associated with increased BCS in patients with cT2-cT4 disease and less extensive axillary surgery in clinically node positive patients with HR+/HER2- tumors. Primary surgery remains the most common treatment strategy in patients with ILC. However, NAC use decreased slightly over the study period, while the use of long-course NET had a small increase and was associated with more BCS and less extensive axillary surgery. Primary surgery remains the most common treatment strat
Like
Comment
Share
